Related Experiment Video
Updated: Mar 15, 2026
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
Published on: April 27, 2014
Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model
Alexis A Dieter1, Jennifer M Wu, Nazema Y Siddiqui
1From the *Department of Obstetrics and Gynecology, Duke University Medical Center, Durham; †Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill; ‡Institute for Medical Research, Durham Veterans Affairs Medical Center; §Department of Surgery, Duke University Medical Center; ∥Department of Research and Development, Durham Veterans Affairs Medical Center, Durham, NC; and ¶Department of Surgery, University of Texas Medical Branch, Galveston, TX.
Onabotulinum toxin type A (BoNT/A) temporarily prolonged rat bladder contractions and reduced voiding efficiency for one week. Subsequent recovery suggests potential compensatory mechanisms or diminishing BoNT/A effects.
Area of Science:
- Urology
- Neuroscience
- Pharmacology
Background:
- Onabotulinum toxin type A (BoNT/A) is used to treat detrusor overactivity.
- Understanding its effects on bladder neuromuscular function is crucial for optimizing therapeutic outcomes.
Purpose of the Study:
- To characterize the temporal effects of intramural BoNT/A injection on rat bladder neuromuscular function over nine weeks.
- To evaluate changes using in vivo cystometry (CMG) and in vitro contractility (IVC).
Main Methods:
- Female Sprague-Dawley rats received either BoNT/A or saline injections into the bladder wall.
- CMG was performed at 1, 3, 6, and 9 weeks post-injection.
- IVC assessed bladder tissue response to electrical stimulation and pharmacological agents.
Main Results:
- Bladder capacity remained unchanged between groups.
- BoNT/A treated rats showed prolonged bladder contractions and reduced voiding efficiency at 1 week, returning to baseline by 3 weeks.
- Enhanced contractile response to carbachol was observed at 3 weeks post-BoNT/A, with no other significant IVC differences.
Conclusions:
- BoNT/A induced transient alterations in rat bladder function, characterized by prolonged contractions and decreased voiding efficiency one week post-injection.
- Functional recovery by three weeks suggests possible compensatory mechanisms like efferent sprouting, increased gap junction formation, or loss of BoNT/A efficacy.
